The Answer to Stopping the Coronavirus May Be Up the Nose
The Covid-19 vaccines authorized for use today were developed at unprecedented speed and surpassed expectations in how well they worked. The billions of people who are protected by them have avoided severe symptoms, hospitalization and deaths. These vaccines are a scientific success beyond measure. And yet they could be even better.Source: The New York Times
Long COVID deep dive, Part 2: ‘I hope someone with the power to change something is listening’
On this episode of Next Question with Katie Couric, Katie unpacks the systemic issues that are impeding patients’ care and conveys the urgent needs of the long COVID community to elected officials.Source: Next Question with Katie Couric
Long COVID deep dive, Part 1: ‘You need to grieve the life you thought you were going to live’
On this episode of Next Question with Katie Couric — part 1 of a two-part series — Katie attempts to understand long COVID — what it is, what it can do to the body, who is affected, and how it is upending lives.Source: Next Question with Katie Couric
Sex-specific Immune Response in COVID-19 Linked to Cellular Metabolism
Researchers studying COVID-19 patients have found a metabolic pathway that is highly correlated with immune responses only in male patients, a group known to be more likely to suffer severe cases and die of the disease, representing a potential target for therapeutic intervention.Source: Yale News
As Covid dissipates in the U.S., cold and flu viruses may return with a vengeance
A curious thing happened during the Covid-19 pandemic: With masks, social distancing, and Purell galore, we kept most other germs at bay. Flu vanished. Cases of respiratory syncytial virus, or RSV, which in a normal winter puts nearly 60,000 children under age 5 in the hospital, were nonexistent. Most of us appeared to sidestep the soup of bugs that cause colds. But as masks come off, schools reopen, and some travel resumes, we should expect a resurgence of these viruses — perhaps a big one.Source: STAT News
Yale to start enrolling young children and pregnant women in COVID-19 vaccine trials
Now that COVID-19 vaccines are being rolled out for adults in much of the world, pharmaceutical companies have started to conduct further trials to confirm whether the shots are also safe and effective for children and pregnant women.Source: Yale Daily News
The science behind why COVID-19 is killing more men than women
Although women contract COVID-19 at a comparable rate as men, the latter is more likely to develop critical manifestations of the disease--irrespective of age or region. In fact, on balance, men are 60% more likely to succumb to COVID-19 than women.Source: Ladders
Women's Health in the Time of COVID-19 Webinar
Uncovering how the coronavirus affects the biology of women and men differently is teaching us new ways to fight COVID-19. Identifying how the stress of the pandemic is different for women and men is focusing mental health professionals on risk and resilience. Watch Women’s Health Research at Yale Director Carolyn M. Mazure, Ph.D, and leading immunologist Akiko Iwasaki, Ph.D., in conversation with Yale Medalist Susanna Krentz, '80, as they discuss a major new research finding and next steps in investigating sex differences to advance the health of women and men.
Yale Engage COVID 19 Inflammation & Genetics, Where Biology Meets Translation
On June 3, 2020, nearly 350 industry representatives and academics joined the inaugural Yale Engage webinar series, Facilitating Collaboration to Combat COVID-19. Opening remarks were made by Michael Crair, PhD, the conversation was moderated by Ruth Montgomery, PhD, and the highly informative panelists included Akiko Iwasaki, PhD, Ellen Foxman, MD, PhD, Naftali Kaminski, MD, Carrie Lucas, PhD, Andrew Wang, MD, PhD. If you were unable to attend, or if you missed a portion of the webinar, please find a link to the recording below, along with a PDF of the panelists’ presentations.
Why Is COVID-19 Striking Men Harder Than Women?
Women's Health Research at Yale Director Carolyn M. Mazure and Immunobiology Professor Akiko Iwasaki, discuss how understanding why men suffer more severe cases of COVID-19 and are more likely to die is vital for developing effective strategies that can produce better outcomes for everyone.Source: Time